Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells. | Front Immunol | 2021 | 34349770 | PubTator, text mining | PubMed |
| The Actin-Disassembly Protein Glia Maturation Factor γ Enhances Actin Remodeling and B Cell Antigen Receptor Signaling at the Immune Synapse. | Front Cell Dev Biol | 2021 | 34336818 | PubTator, text mining | PubMed |
| The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy. | J Oncol | 2021 | 34335756 | PubTator, text mining | PubMed |
| Mechanosensation and Mechanotransduction in Natural Killer Cells. | Front Immunol | 2021 | 34335592 | PubTator, text mining | PubMed |
| Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models. | Front Immunol | 2021 | 34335584 | PubTator, text mining | PubMed |
| A Minimalistic Coumarin Turn-On Probe for Selective Recognition of Parallel G-Quadruplex DNA Structures. | ACS Chem Biol | 2021 | 34328300 | PubTator, text mining | PubMed |
| Large Rab GTPases: Novel Membrane Trafficking Regulators with a Calcium Sensor and Functional Domains. | Int J Mol Sci | 2021 | 34299309 | PubTator, text mining | PubMed |
| Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation. | Commun Biol | 2021 | 34294876 | PubTator, text mining | PubMed |
| Identification of prognostic alternative splicing events in sarcoma. | Sci Rep | 2021 | 34294833 | PubTator, text mining | PubMed |
| Rac-dependent feedforward autoactivation of NOX2 leads to oxidative burst. | J Biol Chem | 2021 | 34293347 | PubTator, text mining | PubMed |
| An integrative study of genetic variants with brain tissue expression identifies viral etiology and potential drug targets of multiple sclerosis. | Mol Cell Neurosci | 2021 | 34284104 | PubTator, text mining | PubMed |
| A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy. | Int J Mol Sci | 2021 | 34281234 | PubTator, text mining | PubMed |
| 3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells. | Front Cell Dev Biol | 2021 | 34277604 | PubTator, text mining | PubMed |
| The Role of Non-coding RNAs in Alzheimer's Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers. | Front Aging Neurosci | 2021 | 34276336 | PubTator, text mining | PubMed |
| Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins. | Nat Commun | 2021 | 34267198 | PubTator, text mining | PubMed |
| LFA-1 in T cell priming, differentiation, and effector functions. | Trends Immunol | 2021 | 34266767 | PubTator, text mining | PubMed |
| Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG). | Br J Haematol | 2021 | 34258755 | PubTator, text mining | PubMed |
| Regulatory interplay between Vav1, Syk and β-catenin occurs in lung cancer cells. | Cell Signal | 2021 | 34252536 | PubTator, text mining | PubMed |
| KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. | Sci Immunol | 2021 | 34244312 | PubTator, text mining | PubMed |
| Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS). | Cancer Manag Res | 2021 | 34239326 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=36